BGI Genomics (SHE:300676) received a proposal from controlling shareholder Shenzhen BGI Genomics Technology to repurchase between 250 million yuan and 500 million yuan of shares, according to a Tuesday after-market filing.
BGI Genomics (SHE:300676) received a proposal from controlling shareholder Shenzhen BGI Genomics Technology to repurchase between 250 million yuan and 500 million yuan of shares, according to a Tuesday after-market filing.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.